The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain

Journal of Neurochemistry

Volumn 125, Issue 3, 2013, Pages 362-372

  Gandía, Jorge ^a   Fernández Dueñas, Víctor ^a   Moratõ, Xavier ^a   Caltabiano, Gianluigi ^b   González Muñiz, Rosario ^c   Pardo, Leonardo ^b   Stagljar, Igor ^d   Ciruela, Francisco ^a  

^a Unitat de Bioquimica   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

cell surface expression; cytotoxicity; GPR37; orphan receptor; Pael R; Parkinson's disease

Indexed keywords

CASPASE 3; CYSTEINE; G PROTEIN COUPLED RECEPTOR; PARKIN ASSOCIATED ENDOTHELIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL STRAIN HEK293; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYSTEINE RICH DOMAIN; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; GEL ELECTROPHORESIS; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANALYSIS OF VARIANCE; ANTIBODIES; BIOTINYLATION; CALCIUM; CASPASE 3; CELL LINE, TRANSFORMED; CELL SURVIVAL; CYCLIC AMP; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; INTRACELLULAR FLUID; MUTATION; NEUROPEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PYRROLIDONECARBOXYLIC ACID; RECEPTORS, G-PROTEIN-COUPLED; THAPSIGARGIN; TRANSFECTION;

EID: 84876692823     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12196     Document Type: Article

References (42)

1. Bodenmuller H., Schaller H. C., and, Darai G., (1980) Human hypothalamus and intestine contain a hydra-neuropeptide. Neurosci. Lett. 16, 71-74.
2. Burgueno J., Enrich C., Canela E. I., Mallol J., Lluis C., Franco R., and, Ciruela F., (2003) Metabotropic glutamate type 1alpha receptor localizes in low-density caveolin-rich plasma membrane fractions. J. Neurochem. 86, 785-791.
3. Burgueno J., Canela E. I., Mallol J., Lluis C., Franco R., and, Ciruela F., (2004) Mutual regulation between metabotropic glutamate type 1alpha receptor and caveolin proteins: from traffick to constitutive activity. Exp. Cell Res. 300, 23-34.
4. Chen L. Y., Chiang A. S., Hung J. J., Hung H. I., and, Lai Y. K., (2000) Thapsigargin-induced grp78 expression is mediated by the increase of cytosolic free calcium in 9L rat brain tumor cells. J. Cell. Biochem. 78, 404-416.
5. Chini B., and, Parenti M., (2009) G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J. Mol. Endocrinol. 42, 371-379.
6. Ciruela F., and, McIlhinney R. A., (1997) Differential internalisation of mGluR1 splice variants in response to agonist and phorbol esters in permanently transfected BHK cells. FEBS Lett. 418, 83-86.
7. Ciruela F., Soloviev M. M., and, McIlhinney R. A., (1999) Cell surface expression of the metabotropic glutamate receptor type 1alpha is regulated by the C-terminal tail. FEBS Lett. 448, 91-94.
8. Ciruela F., Soloviev M. M., Chan W. Y., and, McIlhinney R. A., (2000) Homer-1c/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1alpha: evidence for an anchoring function. Mol. Cell. Neurosci. 15, 36-50.
9. Ciruela F., Burgueno J., Casado V., et al,. (2004) Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem. 76, 5354-5363.
10. Cookson M. R., (2005) The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74, 29-52.
11. Dev K. K., van der Putten H., Sommer B., and, Rovelli G., (2003) Part I: Parkin-associated proteins and Parkinson's disease. Neuropharmacology 45, 1-13.
12. Donohue P. J., Shapira H., Mantey S. A., Hampton L. L., Jensen R. T., and, Battey J. F., (1998) A human gene encodes a putative G protein-coupled receptor highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 54, 152-160.
13. Dunham J. H., Meyer R. C., Garcia E. L., and, Hall R. A., (2009) GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. Biochemistry 48, 10286-10297.
14. Dusonchet J., Bensadoun J. C., Schneider B. L., and, Aebischer P., (2009) Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease. Neurobiol. Dis. 35, 32-41.
15. Forman M. S., Lee V. M., and, Trojanowski J. Q., (2003) 'Unfolding' pathways in neurodegenerative disease. Trends Neurosci. 26, 407-410.
16. Greaves J., and, Chamberlain L. H., (2007) Palmitoylation-dependent protein sorting. J. Cell Biol. 176, 249-254.
17. Harding H. P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., and, Ron D., (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108.
18. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., and, Takahashi R., (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902.
19. Kaufman R. J., (2002) Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110, 1389-1398.
20. Kitao Y., Imai Y., Ozawa K., et al,. (2007) Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum. Mol. Genet. 16, 50-60.
21. Lebon G., Warne T., Edwards P. C., Bennett K., Langmead C. J., Leslie A. G., and, Tate C. G., (2011) Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474, 521-525.
22. Lee A. S., (2005) The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35, 373-381.
23. Leng N., Gu G., Simerly R. B., and, Spindel E. R., (1999) Molecular cloning and characterization of two putative G protein-coupled receptors which are highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 69, 73-83.
24. Low K., and, Aebischer P., (2012) Use of viral vectors to create animal models for Parkinson's disease. Neurobiol. Dis. 48, 189-201.
25. Lujan R., and, Ciruela F., (2001) Immunocytochemical localization of metabotropic glutamate receptor type 1 alpha and tubulin in rat brain. NeuroReport 12, 1285-1291.
26. Marazziti D., Golini E., Gallo A., Lombardi M. S., Matteoni R., and, Tocchini-Valentini G. P., (1997) Cloning of GPR37, a gene located on chromosome 7 encoding a putative G-protein-coupled peptide receptor, from a human frontal brain EST library. Genomics 45, 68-77.
27. Marazziti D., Gallo A., Golini E., Matteoni R., and, Tocchini-Valentini G. P., (1998) Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis. Genomics 53, 315-324.
28. Muchowski P. J., and, Wacker J. L., (2005) Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11-22.
29. Murakami T., Shoji M., Imai Y., Inoue H., Kawarabayashi T., Matsubara E., Harigaya Y., Sasaki A., Takahashi R., and, Abe K., (2004) Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann. Neurol. 55, 439-442.
30. Omura T., Kaneko M., Okuma Y., et al,. (2006) A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin. J. Neurochem. 99, 1456-1469.
31. Rao R. V., and, Bredesen D. E., (2004) Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol. 16, 653-662.
32. Rezgaoui M., Susens U., Ignatov A., Gelderblom M., Glassmeier G., Franke I., Urny J., Imai Y., Takahashi R., and, Schaller H. C., (2006) The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37. J. Cell Sci. 119, 542-549.
33. Schaller H. C., Schilling E., Theilmann L., Bodenmuller H., and, Sachsenheimer W., (1988) Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors. J. Neurooncol. 6, 251-258.
34. Schroder M., and, Kaufman R. J., (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739-789.
35. Shimura H., Hattori N., Kubo S., et al,. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305.
36. Sriram S. R., Li X., Ko H. S., Chung K. K., Wong E., Lim K. L., Dawson V. L., and, Dawson T. M., (2005) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum. Mol. Genet. 14, 2571-2586.
37. Szegezdi E., Logue S. E., Gorman A. M., and, Samali A., (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880-885.
38. Takahashi R., and, Imai Y., (2003) Pael receptor, endoplasmic reticulum stress, and Parkinson's disease. J. Neurol. 250 (Suppl 3), III25-III29.
39. Valdenaire O., Giller T., Breu V., Ardati A., Schweizer A., and, Richards J. G., (1998) A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 424, 193-196.
40. Yang Y., Nishimura I., Imai Y., Takahashi R., and, Lu B., (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37, 911-924.
41. Zeng Z., Su K., Kyaw H., and, Li Y., (1997) A novel endothelin receptor type-B-like gene enriched in the brain. Biochem. Biophys. Res. Commun. 233, 559-567.
42. Zhang Y., Gao J., Chung K. K., Huang H., Dawson V. L., and, Dawson T. M., (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 97, 13354-13359.